Armstrong Advisory Group’s Ascendis Pharma A/S ASND Stock Holding History

Armstrong Advisory Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$684	Buy	+3	New	+$760	﹤0.01%	996

Other funds holding ASND

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Armstrong Advisory Group's ASND Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 3 shares worth $684. The stake represents ﹤0.01% of the portfolio and ranks #996 among its holdings.

10 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Armstrong Advisory Group held 3 shares of Ascendis Pharma A/S worth $684 as of Q3 2026.
Ascendis Pharma A/S was a new Armstrong Advisory Group position in Q3 2026.
Ascendis Pharma A/S made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #996 holding.
10 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.